fbpx

Human trials of COVID-19 vaccine ‘CoronaVac’ generate encouraging results

-

BEIJING, China: A Chinese Company has developed a COVID-19 vaccine and tested it successfully on humans, triggering a hope for millions of people infected by the Novel Coronavirus around the world.

The vaccine ‘CoronaVac’ was developed by a Beijing-based Sinovac Biotech Limited.

The Company launched the trial process at the Jiangsu Provincial Center for Disease Control and Prevention in eastern China, as per the Daily Mail.

The initial reports suggested that the human trials yielded encouraging results as none of the volunteers ranging from between 18 to 59 years of age suffered any side effects while more than 90 percent of them developed an immune response to the COVID-19.COVID-19 vaccine - A Chinese Company has developed a COVID-19 vaccine and tested successfully it on humans, triggering a hope for millions of people infected by the Novel Coronavirus around the world. The vaccine ‘CoronaVac’ was developed by a Beijing-based Sinovac Biotech Limited. The Company launched the trial process at the Jiangsu Provincial Center for Disease Control and Prevention in eastern China, as per the Daily Mail. The initial reports suggested that the test yielded encouraging results as none of the volunteers ranging from between 18 to 59 years of age suffered any side effects while more than 90 percent of them developed an immune response to the COVID-19. The Sinovac Biotech Limited said that the vaccine is safe, and it has gone through two testing phases while the paperwork is underway to initiate the third phase of trials. In a statement, the Chairman, President and CEO of Sinovac Weidong Yin said that “Our Phase I/II study shows CoronaVac is safe and can induce immune response.” “Concluding our Phase I/II clinical studies with these encouraging results is another significant milestone we have achieved in the fight against COVID-19,” Weidong Yin said. It’s worth mentioning that as per the World Health Organization (WHO), more than 130 trials are currently under way across the World to develop a vaccine against COVID-19.

The Sinovac Biotech Limited said that the vaccine is safe, and it has gone through two testing phases while the paperwork is underway to initiate the third phase of trials.

In a statement, the Chairman, President, and CEO of Sinovac Weidong Yin said that “Our Phase I/II study shows CoronaVac is safe and can induce an immune response.”

“Concluding our Phase I/II clinical studies with these encouraging results is another significant milestone we have achieved in the fight against COVID-19,” Weidong Yin said.

It’s worth mentioning that as per the World Health Organization (WHO), more than 130 trials are currently underway across the world to develop a vaccine against COVID-19.

Mati
Mati-Ullah is the Online Editor For DND. He is the real man to handle the team around the Country and get news from them and provide to you instantly.

Must read

Latest article

Enable Notifications for more content    OK No thanks